EQS-Ad-hoc: MBB SE / Key word(s): Preliminary Results/Personnel Disclosure of inside information acc. to Article 17 MAR MBB beats its 2024 guidance with revenues of €1.06 billion at an EBITDA margin of more than 13% based on preliminary figures and announces management changes Berlin, 16 January 2025 – MBB SE (ISIN DE000A0ETBQ4), a medium-sized family business, grew revenues by 11% to around €1,060 million in 2024, based on preliminary figures. At more than 13%, the adjusted EBITDA margin was not only almost 5 percentage points higher than in the previous year, but also exceeded the forecast of 12%, which had already been raised twice during the year. The main driver of this positive development was once again Friedrich Vorwerk, whose revenues of more than €495 million at an EBITDA margin of around 16% were well above expectations. Although MBB invested more than €58 million in the purchase of shares of MBB companies over the course of the year, the MBB Group's Net Cash reached a new record level of around €550 million at the end of the year, up around €75 million on the previous year. Dr Constantin Mang (CEO) and Dr Jakob Ammer (COO) informed the Board of MBB SE at today's extraordinary Board meeting of their decision not to extend their management contracts, which expire on 30 June 2025. Dr Mang has been an integral part of the MBB team for more than 10 years. In almost seven years as a member of the Executive Management and in particular in the last four years as CEO of the Group, he has played a key role in the exceptional development of MBB. His successes include the IPO of Aumann as well as the acquisition and subsequent IPO of Friedrich Vorwerk. Dr Ammer has played a key role in shaping the operational development of MBB's subsidiaries since joining the company in 2020 and especially in the past four years as COO. In particular, he has provided strategic support for Friedrich Vorwerk's rapid growth and has made important contributions to the Group’s organizational development. The Board deeply regrets their decision and wishes to thank them for their outstanding achievements. Dr Christof Nesemeier, founding shareholder and Executive Chairman, and Torben Teichler will jointly lead the company as its Executive Management from July 2025. Dr Nesemeier was today appointed by the Board as Executive Director for a further 4.5 years. As Executive Chairman, he will be responsible for Strategy, M&A and Operations. Mr Teichler was today appointed as CFO of MBB for a further term of 4.5 years and will be responsible for Capital Allocation, Finance and Investor Relations. The Annual Report 2024 will be published on 31 March 2025 at www.mbb.com. MBB SE End of Inside Information
16-Jan-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | MBB SE |
Joachimsthaler Strasse 34 | |
10719 Berlin | |
Germany | |
Phone: | +49 (0) 30 844 15 330 |
Fax: | +49 (0) 30 844 15 333 |
E-mail: | anfrage@mbb.com |
Internet: | www.mbb.com |
ISIN: | DE000A0ETBQ4 |
WKN: | A0ETBQ |
Indices: | PXAP |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2069213 |
End of Announcement | EQS News Service |
|
2069213 16-Jan-2025 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.